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ABSTRACT
Effects of Acetaminophen on Estrogen-Responsive Alkaline Phosphatase Activity
in Ishikawa Endometrial Cancer Cells
Janet A. Dowdy
This study examines the effect of acetaminophen (APAP) on the estrogen-responsive
gene alkaline phosphatase in Ishikawa endometrial cancer cells. Basal levels of alkaline
phosphatase activity were significantly inhibited in cells treated with 0.03, 0.1, 0.3 and 1mM
APAP compared to control. Alkaline phosphatase activity induced with 1nM estradiol was
significantly inhibited in a concentration dependent manner by 0.0.1, 0.3 and 1mM APAP.
APAP did not directly inhibit the activity of alkaline phosphatase at any of the concentrations
tested. Increasing estradiol concentrations (0.01, 0.1 and 1nM) did not alter the level of inhibition
of alkaline phosphatase activity by 0.1, 0.3 or 1mM APAP. This is in agreement with other
studies, which have concluded that APAP does not compete with estradiol for binding at the
estrogen receptor (Harnagea-Theophilusa et al., 1999; Isenhower et al., 1986; Miller et al.,
1999). Protein concentrations were significantly decreased in Ishikawa cells with 0.3 and 1mM
APAP alone or in the presence of 0.01, 0.1 to 1nM estradiol. Inhibition of alkaline phosphatase
activity by high levels (0.3 and 1mM) of APAP may be in part due to toxic effects of APAP as
determined by LDH release. Fluorescent microscopy using calcein staining techniques show that
Ishikawa cells treated with 1nM E2+0.3mM APAP are visibility misshapen; cells treated with
1nM E2+1mM APAP are no longer attached to the plate indicating toxicity. The final part of this
study looked at the interaction between antiestrogen-4-hydroxy tamoxifen (OHT) and APAP on
alkaline phosphatase activity in Ishikawa cells. While OHT inhibited alkaline phosphatase
activity ~50 percent in estradiol-induced cells, addition of 0.03-1mM APAP increased inhibition
significantly in a concentration dependent manner. Results of this study indicate that APAP
decreases estrogen-responsive alkaline phosphatase activity in Ishikawa cells in vitro, and that
this inhibition is not attributed to direct inhibition of enzyme activity.
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Introduction
Endocrine Disrupters and Acetaminophen
Endocrine Disrupters (EDs) are exogenous agents that interfere with the synthesis,
secretion, transport, binding or elimination of natural hormones in the body. Although most
known EDs, such as 1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane (DDT), have estrogen-like
activity, it is possible for EDs to possess antagonist activity or to cross talk between different
endocrine pathways. The significance of alterations to endocrine processes includes disruption in
hormone-mediated functions such as maintenance of homeostasis, reproduction, development,
and/or behavior. Wildlife studies have shown the impact of EDs, such as DDT and
polychlorinated biphenyls (PCBs), upon animal populations. Effects of these environmental EDs
upon the human population are inconclusive, yet the worldwide increases in reproductive organ
cancers (Brasso et al., 1999; Giwercman et al., 1993; Hill et al., 1983; Murphy et al., 1999; Sant
1999 et al., Wingo et al., 1998), ectopic pregnancies (Rajkhowa et al., 2000), male urogential
malformations (Weidner et al., 1998; Paulozzi et al., 1997), and decreased sperm count (Swan et
al., 1999) cause concern that EDs may be impacting human health.
Acetaminophen (APAP), a commonly used analgesic/antipyretic, is currently being
investigated as a possible xenoestrogen. APAP contains a p-hydroxyl group and lipophylic
conjugated six-member ring structure like estradiol (Cunningham et al., 1997). In vitro studies
have shown that acetaminophen has the ability to induce estrogen-mediated DNA synthesis and
cell proliferation in estrogen receptor positive (ER+) breast cancers cells (Harnagea-Theophilus
et al., 1998) and inhibits estradiol-induced vitellogenin production in trout liver cells (Miller et
al., 1999). Although no estrogenic activity was observed in uterotropic bioassays (HarnageaTheophilusb et al., 1999, Isenhower et al., 1986), animal studies have shown that APAP reduced
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the number of litters per breeding pair, increased abnormal sperm counts and increased testicular
atrophy in mice (Boyd et al., 1970, Reel et al., 1992). Even more significant are case studies
indicating that APAP has endocrine altering effects in the human population such as lowering
basal hormone levels in women (Cramerb et al., 1998) and reducing the risk of ovarian cancer
(Cramera et al., 1998). In combination, these studies suggest that APAP is impacting endocrine
function not only in in vitro and animal studies but also within the human population taking this
drug.

Wildlife Studies
Environmental contaminants have posed a threat to wildlife since the beginning of the
industrial age. The theory that environmental pollutants, such as organochlorine pesticides and
industrial waste, could have endocrine disrupting effects is a newer concern. The 1979 National
Institute of Health’s “Estrogens in the Environment” symposium was the beginning of
investigation into the endocrine disrupting potential of man-made chemicals being released into
the environment (Guilleteb et al., 1995; McLachlan et al., 1992)(Fig.1). The connection between
wildlife health effects and environmental exposure to endocrine disrupting chemicals has been
well established. In addition, laboratory studies have shown that xenobiotics with estrogenic
activity significantly alter both embryonic development and adult reproductive function in
different animal models. The significance of these studies must be addressed to fully understand
the impact that xenobiotic exposure could have upon the human population.
Effects of Xenobiotics in Reptiles and Amphibians
Aquatic animals are exposed to chemical pollutants dermally, orally, and through the
food chain. While most environmental contamination occurs due to agricultural and urban use of
pesticides, industrial waste is also a significant source and can pose a serious threat to wildlife.
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One such example is the chemical spill by the Tower Chemical Company at Lake Apopka,
Florida in 1980 (Semenza et al., 1997). That extensive chemical spill, which consisted mostly of
difocal and DDT, led to registration of the lake as an EPA Superfund contamination site
(Guillette et al., 1994). By 1994 the American alligator (Alligator mississippiensis) population at
Lake Apopka had fallen to one tenth of its original number since 1970 and elevated levels of
p,p’-DDE were found in the alligator eggs collected from the lake between 1984-85 (Guillette et
al., 1994; Jennings et al., 1998, Woodward et al., 1989).
While poor egg viability could not be directly correlated to the elevated organochlorine
levels (Heinz et al., 1991), the observed concentrations (5.8ppm wet weight) were known to
cause adverse effects in avian embryos (Cooper et al., 1991). Juvenile alligators obtained as eggs
from Lake Apopka had significantly increased serum levels of p,p’-DDE, dieldrin, endrin, mirex,
oxychlordane, DDTs, and PCBs compared to juveniles from uncontaminated Florida lakes
(Guillette et al., 1999). However, the most disturbing aspect of these studies indicated changes in
gonad morphology in both male and females alligators as well as changes in plasma sex steroid
levels. Guillette reported that female alligators had plasma estrogen levels two times higher than
normal along with the abnormal formation of ovaries. Male alligators had plasma testosterone
levels three times lower than normal, malformed testes, and decreased phallus size (Guillette et
al., 1996).
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Fig.1. Structures of estradiol, DES and suspected xenoestrogens
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In vitro studies examining steroidogenic activity of gonadal tissue from juvenile
alligators showed changed in estradiol synthesis. Estrogen synthesis was increased in males and
decreased in females; however, no significant differences in testosterone production were
observed. Differences noted between steroid levels in vivo and in vitro studies may be explained
by steroid synthesis and degradation processes that occur in the whole animal but not in in vitro
studies (Guillettea et al., 1995). These studies support Guillette’s theory that chemicals spilled
into Lake Apopka in 1980 have modified both reproductive and endocrine development
permanently in resident alligators in ovo.
Receptor binding studies have shown that some environmental chemicals possess the
ability to bind alligator estrogen (aER) and alligator progesterone (aPR) receptors, which are
present in the alligator oviduct (Vonier et al., 1997). p,p’-DDD and trans-nonaclor, both found in
Lake Apopka following the chemical spill, interacted with aER while chlordane and toxaphene
did not. However, when combined, these chemicals decreased [3H]-estradiol binding to aER in a
greater than additive manner (Vonier et al., 1996). Chlordane, dieldren and toxaphene, which
possess little appreciable estrogenic activity alone, in combination, act synergistically upon both
alligator and human ER (Arnold et al., 1997).
Temperature-dependent sex determination studies (TDS) show that estrogen has the
ability to reverse effects of a male-producing temperature in red-eared slider turtles (Trachemys
scripta) (Crews et al., 1995, Willingham et al., 1999) and alligators (Alligator mississippiensis)
(Bull et al., 1980; Guillettea et al., 1995). In TDS, each egg has the potential to develop into a
male or female as determined by the incubation temperature present at critical developmental
periods. Temperature acts as a trigger to begin the cascade of biochemical events that lead to
sexual development of one gender or the other. Sex steroids play an interactive role in TSD;
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however, that role is not completely understood (Crews et al., 1995; Willingham et al., 1999).
Xenobiotics suspected of being estrogenic were assayed at the concentrations found in alligator
eggs from Lake Apopka. Those eggs incubated at a male-producing temperature with trans- and
cis-Nonclor, aroclor 1242, p,p’-DDE or chlordane, alone or in combination, all produced
significant sex reversal from male to female in red-eared slider turtles (Willingham et al., 1999).
These studies demonstrate some of the more subtle effects that endocrine disrupting chemicals
may have in reptile and amphibian populations.
Xenoestrogens and Reproductive Failure in Birds
Bioaccumulation of pesticides in predatory birds is a result of the widespread use,
accumulation, and run-off of agricultural chemicals into aquatic environments. These
contaminants are stored in the fatty tissue of fish and are consumed by predatory birds as well as
other wildlife. Organochlorine pesticides, such as DDT, polychlorinated biphenols (PCBs),
dioxins and dibenzofurans that have been identified as xenoestrogens, are linked to the
reproductive failure in many avian species such as grebes (Rudd 1972), ospreys (Spitzer et al.,
1978), falcons (Cade et al., 1971), bald eagles (Cromartie et al., 1975) and cormorants (Ludwig
et al., 1996). Due to the lipophylic nature of these contaminants, they are not only stored in the
fat tissues of exposed birds but are, in addition, passed to their offspring by deposition into the
yolks of their eggs (Fry et al., 1981).
Avian embryos are especially sensitive to the effects of contaminants because they cannot
be excreted and thus remain within the embryonic circulation throughout the incubation period.
Metabolites of parent compounds can be more bioactive, as is the case of op’-DDT and
methoxychlor, compounds which have been identified as weak xenoestrogens. Their
hydroxylated metabolites have binding affinities almost equal to that of estradiol in estrogen
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receptor binding studies (Bulger et al., 1978). In addition, many organochlorine compounds are
inducers of chick embryo liver mixed-function oxidases (Rodman et al., 1991) and could
possibly compound the level of estrogenic exposure by increasing the rate of metabolic
activation of the weaker parent compound.
Some effects of xenoestrogen exposure seen in birds are different than those found in
mammals due to differences in steroid hormonal control during embryonic development. In
contrast to mammals, male is the default sex in birds during sexual differentiation. Chick
embryos differentiate from male to female only when estrogen is produced, resulting in the
formation of the gonads into an ovary (Fry et al., 1995). Primordial germ cells (PGC), which
migrate into the indifferent gonads during mid-gestation, by default end up in the seminiferous
tubules in males (Romanoff et al., 1960). Estradiol induces development of the ovarian structure,
regression of the right cortex and localization of PCG into the left cortex, which develops into an
ovary (Fry et al., 1995). Gull eggs injected with op’-DDT or methoxychlor mimicked effects
seen with estradiol or DES and developed abnormalities in both male and female embryos. Male
embryos showed abnormal development of an oviduct or ovarian type tissue, and PGCs became
localized in this ovarian-like tissue as well as in the seminiferous tubules. The right oviduct only
partially regressed in females (Boss et al., 1947; Fry et al., 1987; Romanoff et al., 1960). DDT
feminization has been associated with the inability of male gulls to breed and the high ratio of
female to male gulls on Santa Barbara Island in Southern California (Fry et al., 1981).
However, the most dramatic effect of DDT is eggshell thinning in exposed birds. While
the inhibition of Ca2+-ATPase activity by DDT is well known, DDT also strongly inhibits the
binding of progesterone and testosterone to their respective receptors located in the eggshell
mucosal gland (Lunholm et al., 1991). In addition, DDT-induced eggshell thinning may be due
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to an estrogenic effect. Hens exposed to estrogen as chicks produced defective, thin, or soft eggs
in adulthood (Greenwood et al., 1938). Studies of Japanese quail exposed to DDT during
embryonic development demonstrated not only increased eggshell malformations as adult hens,
but also had long-term effects upon their reproductive behaviors (Bryan et al., 1989).

Human Risk
While the health effects of endocrine disruption upon wildlife have been well
documented, the human risk is not as clearly defined. Human pathologies and disorders that may
be related to EDs include increased incidence of: breast and female reproductive tract cancers
(Hill et al., 1983; Sant et al., 1999; Wingo et al., 1998); prostate cancers (Brasso et al., 1999;
Giwercman et al., 1993; Murphy et al., 1999); ectopic pregnancies (Rajkhowa et al., 2000);
cryptorchidism and hypospadius (Paulozzi et al., 1997; Weidner et al., 1998); and a 50%
decrease in sperm counts within the last 50 years (Swan et al., 1999). These trends in
reproductive disorders and disease mimic the effects seen in both human diethylstilbestrol (DES)
exposure and in studies of animals exposed to endocrine disrupting compounds.

Diethylstilbestrol: An Example of Endocrine Disruption
Diethylstilbestrol (DES) is an estrogenic drug that was used therapeutically from 19401970 by approximately 6 million women worldwide to prevent habitual or spontaneous abortion.
Adverse reactions to DES only appeared 12-15 years after exposure in the children of those
women who took the drug during pregnancy. These side-effects range from infertility and
reproductive tract anomalies to increased risk of rare cancers, and continue to appear in third
generations (Dukes, 1996). In 1987, the Registry for Research on Hormonal Transplacental
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Carcinogenesis reported that 60% of vaginal or cervical clear-cell carcinoma documented cases
were in women who had been exposed to DES in utero. Exposed female children have a 30%
probability of developing cervical vaginal adenosis during adolescence, which can develop into
clear-cell adenocarcinoma. In addition to reproductive disorders, these women also have a 50%
greater chance of developing autoimmune disease (Dukes, 1996). Exposed male children are at
risk for a variety of reproductive disorders including cryptochordism, urethral abnormalities,
epididymal cysts, testicular hypoplasia, decreased semen quality, and a doubled risk of
developing testicular cancer (Toppari et al., 1996). DES case studies represent the only known
data on the catastrophic effects of an estrogenic compound upon the human population.
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Effect of DES and Suspected Endocrine Disruptors in Animal Studies
There have been extensive studies showing that prenatal DES exposure in rodents, at
concentrations equivalent to the human therapeutic dose, produce similar effects upon fertility,
reproductive tract development and function. Female mice exposed in utero had a dosedependent decrease in fertility, vaginal adenocarcinoma, cervical enlargement, cystic
endometrial, ovarian tumors, and congenital malformations (McLachlan et al., 1980; Newbold et
al., 1995). These reproductive tract lesions and fertility problems are very similar to those
reported clinically in DES-exposed women. In rats, male offspring had a 5% risk of developing a
rare testis cancer and a 92% risk of having retained testis or cryptochordism (Newbold et al.,
1995). As in the human exposure-effect, these reproductive anomalies are not always apparent in
the offspring at birth. Male hamsters exposed to DES prenatally appeared normal at pubertal age,
but as adults exhibited multiple lesions in reproductive tracts, spermatogenesis, cryptochordism
and testicular tumors (Khan et al., 1998).
Prenatal exposure to compounds suspected of causing endocrine disruptive activity, such
as PCBs and phytoestrogens, have been shown to impact both reproductive system development
and sexual behavior in male rats in the same manner as DES. Prenatal exposure to 4-octylphenol
(OP), butyl benzyl phthalate (BBP), or Bis-phenol A all cause decreases in testicular size and
sperm count (Sharpe et al., 1995; vom Saal et al., 1998). Phytoestrogens cause alterations in the
development of the CNS-gonadal axis and male sexual behavior (Santti et al., 1998). In utero
and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCCD) decreases plasma
testosterone levels at birth and causes a permanent decrease in testicular size (Mably et al.,
1992). Chronic OP exposure of the adult animal decreases serum LH, FSH and testosterone
(Blake et al., 1997), shrinkage of reproductive organs, and increases in sperm deformities
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(Boockfor et al., 1997). Benzene-based dyes, antiandrogenic fungicides, TCCD and PCB 169
exposure have all been correlated with abnormal rodent sex differentiation (Gray et al., 1999).
Aroclor, as well as the chlorobiphenyl (CB) congeners CB47 and CB153, has shown estrogenic
activity in female rat uterotropic studies (Soontornchat et al., 1994).

Human exposure to Suspected Endocrine Disrupting Compounds
Evidence of endocrine-disrupting effects upon the human population is complex,
controversial and very limited. However, there are several studies examining the effects of PCBs
upon human development and the relationship between organochlorines and development of
breast cancer in women.
Prenatal PCB exposure through maternal consumption of contaminated fish from
the Upper Great Lake Region increases the risk of lower birth weight, smaller head
circumference (Fein et al., 1984), and decreased reflex and autonomic processing on the
Neonatal Behavior Assessment Scale (NBAS) in the newborn (Lonky et al., 1996). Postnatal
exposure through lactation most significantly decreased physical activity levels (Jacobson et al.,
1989). A follow up study of prenatally exposed 4-year-olds indicates that these children continue
to have poor cognitive function in terms of short-term memory and processing speed (Jacobson
et al., 1993). While estrogen receptor subtypes α and β are both expressed in various regions of
the human brain (Beyer et al., 1999), their role in development of the central nervous system
(CNS) is not completely understood. It is becoming more apparent that estrogen is important not
only in sexual differentiation and reproductive neuroendocrine function, but also in neuron
growth and differentiation (Toran-Allerand et al., 1999). Whether or not PCBs act with
estrogenic activity upon the CNS during human fet al. development has yet to be determined.
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Less conclusive studies have suggested that EDs may be responsible for higher male:female sex
ratio of birth defects (urigenital / cardiovasculature / CNS) amongst pesticide appliers in
Minnesota (Garry et al., 1996); significant alteration in the male:female ratio in occupational
carbon setters (Milham et al., 1993), and permanent changes in sperm production in farm
sprayers exposed to 2,4-dichlorophenoxyacetic acid (2,4-D) (Lerda et al., 1991).
Environmental organochlorines, such as PCBs and DDE, are being investigated as
possible risk factors in breast cancer of women. Case studies show that the cancerous breast
tissue obtained from women has a 62% higher concentration of p,p’-DD and 25% increase in
PCB118 (Guttes et al., 1998) compared to normal healthy tissue. Another study found that serum
samples taken near the time of breast cancer diagnosis showed a positive correlation between the
serum levels of PCB118, PCB 138, hexachlorobenzene, dieldrin and breast cancer incidence in
women (Dorgan et al., 1999; Guttes et al., 1998; Hoyer et al., 1998). The New York University
Women’s Health Study from 1985-1991 indicated that DDE increased breast cancer risk 4-fold
while PCBs increased risk less than two-fold (Wolff et al., 1993). Other studies have found no
correlation between serum organochlorine levels and incidence of breast cancer in women
(Helzlsouer et al., 1999; Krieger et al., 1994). The contribution of organochlorines to the risk of
the development of breast cancer is still controversial. However, the fact remains that
organochlorines are present in significantly higher concentrations in the adipose tissue and serum
of women in high-risk locations such as Long Island, New York (Stellman et al., 1998). Because
of their prevalence in the environment, further investigation is necessary to discern the possible
contribution of xenoestrogens to the development of breast cancer in women.

13
Acetaminophen
Acetaminophen (APAP) is a widely used analgesic and antipyretic found in more than
850 over-the-counter and prescription formulations (Prescott et al., 1996) (Fig.2.). APAP exerts
its analgesic and antipyretic activity through selective inhibition of the cyclo-oxygenase
isoenzyme in the central nervous system. APAP is a weak inhibitor of peripheral cyclooxygenase and possesses only very weak anti-inflammatory effects (Welch and Martin 1995,
Rang and Dale 1997).
Fig.2. Structure of Acetaminophen
ACETAMINOPHEN
NHCOCH3

OH

Acetaminophen metabolism (Fig.2.) occurs primarily in the liver where it is conjugated
with glucuronide or sulfate and then readily excreted in the urine (Jollow 1973, 1974). Mixedfunction-oxidases (MFOs) can also metabolize APAP forming a highly reactive metabolite, Nacetyl-p-benzoquinone (NAPQI), which is inactivated by binding to intracellular glutathione
(Dahlin 1984). However, if the glutathione stores within the cell become depleted, such as in the
case of APAP overdose, NAPQI will covalently bind to cysteine residues of cellular proteins as a
3-(cystein-S-yl)-APAP adduct (Hinson 1980, Mitchell 1973). The depletion of glutathione due to
certain disease states, such as liver cirrhosis or necrosis, also can lead to APAP toxicity due to
NAPQI accumulation following chronic drug administration or high doses. In addition,
individuals who may have induced P450 MFOs due to alcoholism or therapeutic drugs also run
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the risk of toxicity due to increased metabolic production of NAPQI (Welch and Martin 1995).
The site and amount of relevant covalent binding has been directly correlated with the
development of APAP toxicity in humans and laboratory animals (Hinson et al., 1995; Ray et
al., 2000). Administration of N-acetylcysteine decreases NAPQI covalent binding and its
associated toxicity (Piperno et al., 1976).
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Fig. 3. APAP Metabolism
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Acetaminophen has been shown to have various other effects upon cells in both in vitro
and animal studies. At therapeutically relevant concentrations, APAP inhibits cell proliferation in
HL-60 (Wiger et al., 1997), HepG2 (Dai et al., 1995), and V79 Chinese hamster cells (Holme et
al., 1988); increases chromosomal breaks and inhibits DNA synthesis (Holme et al., 1988;
Honglso et al., 1991); and down regulates c-myc and bcl-2 mRNA (Wiger et al., 1997). These
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effects do not appear to be a result of formation of the toxic metabolite NAPQI as HepG2 (Dai et
al., 1995) and V79 cells (Kappers et al., 2000) do not express endogenous P450 activity.
In vitro studies in mouse and rat indicate that cytotoxic concentrations of APAP bind
DNA, increase single strand breaks (SSBs), and interfere with DNA repair and synthesis
(Honglso et al., 1994). In addition to hepatotoxicity (Tonge et al.,1998), high doses of APAP
target mouse testis DNA synthesis resulting in decreased testicular weight, decreased number of
spermatocytes, and deterioration in sperm chromatin structures (Wiger et al., 1995).
Genotoxic effects are also apparent as chromosomal aberration in humans. In two of the
three studies conducted with human volunteers taking a maximum daily dose of APAP (3 x 1000
mg over 8-hours), there was a significantly higher frequency of chromatid breaks in peripheral
lymphocytes 24 hours later (Hongslo et al., 1991).

APAP as a Possible Endocrine Disrupter
Recent studies have shown that APAP has the ability to alter estrogen responses in vitro
in ER+ breast cancer cells. One study examined the effect of therapeutic concentrations of APAP
upon estrogen-mediated DNA synthesis in ER+/PR+ and ER-/PR- breast cancer cells (HarnageaTheophilus et al., 1998). Proliferation was determined by [3H]-thymidine incorporation into
DNA and percentage of cells in DNA synthesis (S) phase. While 0.1mM APAP was as effective
as 3nM estradiol at promoting DNA synthesis in ER+/PR+ cells, the combination of APAP and
estradiol was not additive. In addition, cell proliferation was not induced by estradiol or APAP in
ER-/PR- breast cancer cells.
Further studies examined the role of estrogen receptors (ER) in APAP-induced cell
proliferation determined by [3H]-thymidine incorporation into DNA (Harnagea-Theophilusa et
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al., 1999). APAP-induced cell proliferation in MCF7 and T47D (ER+/PR+) cells, but not in
T47co (ER-/PR-) cells. Antiestrogens ICI 182,780 and 4’-hydroxytamoxifen, inhibited APAP
induced proliferation in MCF7 and T47D (ER+/PR+) cells. Estrogen receptor binding studies
were also performed in MCF7 (ER+/PR+) cells, and it was determined that APAP does not
compete with estradiol for binding. The position of the -OH moiety on the benzene ring of APAP
does appear to have an influence upon its ability to mimic estrogen-induced cell proliferation.
Therapeutic plasma concentrations of APAP (0.1mM) induce varying amounts of breast cancer
proliferation depending on the position of the -OH moiety p->m->o-acetaminophenol (HarnageaTheophilusb et al., 1999). These studies concluded that APAP was acting upon estrogen receptormediated cell proliferation in a non-competitive manner with estradiol, and was inhibited by
antiestrogens in ER+/PR+, but not in (ER-/PR-) breast cancer cells. The position of the
hydroxyl-group influences potency of this activity.
Acetaminophen’s estrogenic activity has been investigated in another estrogen-dependent
process, the production of vitellogenin in isolated trout liver cells. Vitellogenin production is an
absolutely estrogen-dependent process in trout liver cells. APAP caused a concentrationdependent decrease of estrogen-induced vitellogenin mRNA and protein in trout liver cell in
vitro studies. APAP (0.05mM) produced 50% inhibition of estradiol-induced vitellogenin
production, while 0.3mM APAP reduced vitellogenin to undetectable levels. ER binding assays
indicate that APAP does not reduce binding of [3H]-estradiol at the receptor (Miller et al., 1999).
Acetaminophen also failed to show significant receptor binding in a soluble uterine receptor
preparation or in an in vivo uterotropic bioassay using immature female mice (Isenhower et al.,
1986). However, an NIH study found that uterine, ovarian, and testicular atrophy occurred in
rodents fed 25,000ppm APAP and ovarian cysts decreased in rodents fed 3,000-6,000 ppm
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(NTP). Case studies conducted at Harvard Medical School found that APAP use is associated
with a decreased risk of ovarian cancer (Cramera et al., 1998) and alters basal gonadotropin and
estradiol levels in women who take APAP for menstrual pain (Cramerb et al., 1998).

Ishikawa Cells as an in vitro estrogen-screen model
Ishikawa cells are a human endometrial adenocarcinoma cell line established in 1985
from an endometrial adenocarcinoma of a 39-year old woman in Japan. This cell line is estrogen
receptor (ER) and progesterone receptor (PR) positive in both in vitro cell cultures and in
induced tumors in mice (Hata et al., 1992; Nishada et al., 1985). Kassan et al. (1989) detected
two different cytosolic estrogen receptors with Kd values of approximately 0.02 and 6nM.
Estradiol has a variety of effects upon Ishikawa cells including: increased cell proliferation
(Holinkaa et al., 1986); upregulation of progesterone receptors (Holinkaa et al., 1986); increased
DNA polymerase α activity (Holinkaa et al., 1986); increased cerbB2/NEU proto-oncogene
protein expression (Markogiamakis et al., 1997); increased intracellular β-endorphin and release
(Makrigiannakis et al., 1992); increased alkaline phosphatase enzyme activity and mRNA
(Albert et al., 1990; Holinkab et al., 1986). Ishikawa cells are not dependent upon estrogen for
cell growth; however, estradiol (E2) does stimulate cell proliferation under serum-free and
growth factor–free conditions (Holinka et al., 1989; Nishada et al., 1985). The extreme
sensitivity of estrogen-inducible alkaline phosphatase in Ishikawa cells makes this cell line ideal
for in vitro estrogen-screening bioassays. Studies by Littlefield et al. demonstrate an estrogen
microtiter assay that detects alkaline phosphatase activity with maximal stimulation at 10-9M E2,
and with detectable stimulation at concentrations as low as 10-12M E2 (Littlefield et al., 1990).
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Antiestrogens have mixed agonist/antagonist activities in Ishikawa cells. 4hydroxytamoxifen (OHT) alone significantly stimulates both alkaline phosphatase activity
(Markewicz et al., 1997) and cell proliferation (Anzai et al., 1989) at concentrations of 1-10µM,
but when combined with estradiol OHT inhibits estradiol-induced activity and cell proliferation
(Simard et al., 1997; Holinka et al., 1996). Although OHT’s partial agonist activities are not well
understood, studies by Barsalou et al. (1998) indicate that it has the ability to bind both the
estrogen-responsive-element (ERE) and AP1 DNA-binding sites in Ishikawa cells. Alkaline
phosphatase activity induced by E2, OHT, Droloxifene or Raloxifene can be overcome by the
complete antagonist EM-800 (Simard et al., 1997). Antiestrogen ICI 164,384 inhibits estradiolinduced alkaline phosphatase at the mRNA level (Albert et al., 1990).

Alkaline Phosphatase
Alkaline phosphatase is an intrinsic membrane protein with a molecular weight of
70,000-125,000 (Ghosh et al., 1968) that exists as a homodimer of homogeneous subunits with
the catalytic site exposed on the extracellular side of the plasma membrane (Rustin et al., 1979).
This enzyme cleaves phosphate groups from phosphate-esters, and, although not completely
understood, it appears to play a role in cell homeostasis and metabolism. In humans alkaline
phosphatase exists in 4 different isotypes: intestinal, placental, liver-bone-kidney, and germ cell
(Frohlander et al., 1991). Clinically, serum alkaline phosphatase levels are used to screen for
bone disease, liver dysfunction, and has been associated with the development of several human
cancers such as lung, ovary, gastrointestinal and uterine cancer by the type of isoenzyme
detected.
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In Ishikawa cells alkaline phosphatase exists in 3 isoenzymes: intestinal, placental and
liver-bone-kidney (McKenna et al., 1979; Mulivor et al., 1985). Immunological assays show that
alkaline phosphatase is present in Ishikawa cells in the following proportions: liver-bone-kidney
77.9%, placental 21.7% and intestinal <1% (Albert et al., 1990). In estradiol-stimulated cells the
placental isoenzyme increases to 43.1%, liver-bone-kidney decreases to 55.1% and intestinal
remains the same (Albert et al., 1990).
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Hypothesis
This study tests the hypothesis that APAP will have estrogen-like activity on
estrogen-inducible alkaline phosphatase activity in Ishikawa cells. Previous studies demonstrate
that APAP has estrogen-like activity in breast cancer cell proliferation studies (HarnageaTheophilus et al., 1998) and inhibits estrogen-induced vitellogenin production in isolated trout
liver cells (Miller et al., 1999). No appreciable interactions between APAP and the estrogen
receptor have been found (Harnagea-Theophilusb et al., 1999, Isenhower et al., 1986) and the
mechanism by which APAP alters these estrogenic-responses is unclear. In addition, case studies
indicate an association between APAP and lowered risk of ovarian cancer and altered basal
hormone levels, including estrogen, in women who take the drug (Cramera,b et al., 1998).
Investigation of APAP's estrogen-altering effects is necessary to identify the possible impact, if
any, that APAP may have upon estrogen-responsive processes in human health and to identify
the mechanism behind this activity.
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Methods
Cell culture
Ishikawa endometrial adenocarcinoma cells were a gift from the laboratory of Jacques
Simard (CHUL Research Center, Quebec, Canada). Ishikawa cells are maintained in Minimum
Essential Media (MEM) (Gibco) supplemented with 10% fetal bovine serum and 0.1%
gentamycin. Cells are incubated at 37°C, 5% CO2 and passed by trypsinization when they reach
~80% confluency.
Studies by Holinka et al. (1989) have shown that Ishikawa cells are able to grow and
retain their estrogen-responsiveness in serum-free medium although maximal cell density is
lower than estrogen supplemented medium. In order to achieve low basal levels of estrogeninducible alkaline phosphatase activity, at least 2 weeks prior to the beginning of an experiment,
cell medium is changed to estrogen-free EFBM consisting of 1:1 combination of phenol red-free
Dulbecco’s Modified Eagle Medium (PRF-DMEM) (Gibco) and F:12 (Ham) Nutrient Mixture
(Gibco), supplemented with 2% stripped fet al. bovine serum (FBS), 1% l-glutamine and 0.1%
gentamycin.
FBS is stripped of steroid hormones by the following charcoal-dextran method. Twenty
milligrams of sulfatase (Sigma) are added to 200ml fet al. bovine serum and incubated at 37°C
for two hours. Twenty grams of activated charcoal (Sigma) are washed twice by addition of
200ml deionized H2O followed by centrifugation at 3000 rpm for 10 minutes. Two grams of
dextran (Sigma) are added to charcoal for 1 hour in 400ml deionized H2O at room temperature
using a spin bar. Twenty milliliters of dextran-treated charcoal (DCC) is centrifuged and
deionized H2O discarded. DCC is added to sulfatase-treated FBS for 30 minutes in a 56°C shaker
waterbath, followed by centrifugation at 3000 rpm for 10 minutes. The DCC is discarded, and
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serum is treated two more times with DCC for a total of three strippings. Final centrifugation is
done at 9,000 rpm for 30minutes at 5°C; serum is filter-sterilized and stored at -20°C.

Alkaline Phosphatase Activity Determination
Alkaline phosphatase is an estrogen-inducible gene in Ishikawa Cells and has been used as a
marker for estrogen-responsiveness in this cell line (Albert et al., 1990, Holinka et al., 1986).
Previous studies have shown that incubating Ishikawa cells for 5 days with increasing
concentrations of estradiol caused up to a maximal 15-fold increase in activity compared with
non-stimulated controls (Simard et al., 1997). The alkaline phosphatase activity assay is a simple
and inexpensive colormetric assay performed in CoStar 96-well cell culture plates as described
by Littlefield et al (1990). Enzyme activity is determined by the rate of conversion of the
colorless substrate para-nitrophenol phosphate (pNPhP) to yellow colored product paranitrophenol (pNPhOH) by cleavage of an inorganic phosphate group (Henthorn et al., 1988):
alkaline
phosphatase

pNPhP + H2O → pNPhOH + HPO4-

As product is formed absorbence increases as measured by spectrophotometer at 405nm.
Alkaline phosphatase activity is determined by calculation from the change in absorbence per
minute to the molar concentration of para-nitrophenol produced per minute per well using the pnitrophenol extinction coefficient. Controls for all experiments include untreated cells to serve as
a negative control showing basal level of activity and estradiol treatment as a positive control to
indicate estradiol-induced alkaline phosphatase activity.
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Calculations:
Xmoles of product p-nitrophenol per well = (1M p-NP/10,000 abs units) x (change in abs./min) x (5x10-5
L)
p-nitrophenol Extinction Coefficient: 1M p-nitrophenol Abs405 = 10,000units
Change in absorbence per minute = AbsT1 –AbsT2 / minutesT1- T2

Induction of Alkaline Phosphatase:
A nearly confluent flask of Ishikawa cells in EFBM is harvested with 0.25% trypsin and
plated in CoStar 96-well plates at 7x103 cells/ml in 100µl aliquots. Cells are allowed to adhere to
plates for 24 hours followed by addition of test compounds in 50µl aliquots. Cells are exposed to
test compounds for 96 hours, with one media change at 48 hours. At the end of the exposure
period individual wells are assayed for cellular alkaline phosphatase activity and total cellular
protein as determined by fluorescamine. Alkaline phosphatase activity was determined for n=5
wells, and protein determination was n=3 per experiment.
At the end of the exposure period media is removed by inversion and plates are rinsed
twice by gentle emersion and swirling in 1 liter of phosphate-buffered saline (PBS). PBS is
shaken out gently by inversion, and plates is blotted with paper towl. Covered plates fozen at 80°C for at least 10 minutes then thawed at 37°C for 3 minutes to lyse cells. Fifty microliters of
5mM para-nitrophenol phosphate solution (23.07mg p-nitrophenol phosphate/10ml diethylamine
MgCl2) are added to each well. Formation of product, para-nitrophenol (pNP), is monitored by a
96-well plate spectrometer (SPECTRAMAX 340PC) at 405nm from 0-60 minutes at 30°C.
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Total Cellular Protein Determination by Fluorescamine
In addition to alkaline phosphatase enzyme activity, total cellular protein was measured
in order to determine to what extent changes in enzyme activity was reflected in protein
concentrations.
Fluorescamine is a reagent that reacts instantaneously with amines to produce
fluorophors (365nm excitation, 475 emission) by the ninhydrin-phenylacetaldehyde reaction.
Fluorescamine as well as its hydrolysis products are nonfluorescent (Udenfriend et al., 1972)
(Fig. 4).
Cells in 96 wells are rinsed and freeze-thawed in the same manner as described in
Alkaline Phosphatase Activity Assay. To each well, 155µl PBS plus 45µl fluorescamine reagent
(0.018g/30ml acetonitrile) are added. Fluorescence is allowed to stabilize for five minutes, then
read with fluorimeter (Cytofluor 400) read at 360nm excitation, 460 emission. Bovine serum
albumin (BSA) standards are prepared in the range of 0-80ug from a 1mg/ml BSA solution and
fluorescence is determined for individual wells. Total cellular protein per individual well is
extrapolated from the albumin standard curve.
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Figure 4. Ninhydrin-phenylacetaldehyde reaction (Reprinted with permission from
Udenfriend, S., et al., (1972) Fluorescamine: a reagent for assay of amino acids,
peptides, proteins, and primary amines in the picomole range. Science. Nov
24;178(63):871. Copyright 1972 American Association for the Advancement of Science.)
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Lactate Dehydrogenase Cytotoxicity Assay
Lactate dehydrogenase (LDH) is a cytosolic enzyme present in all mammalian cells. The
cell membrane is impermeable to LDH under normal healthy conditions; however, damage to the
membrane can result in changes in membrane permeability leading to LDH release into the
extracellular fluid (Rae et al., 1986). This assay is based on the ability of LDH to catalyze the
reaction:

Lactate + NAD+ ⇔ Pyruvate + NADH
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LDH is measured indirectly as the rate of change in absorbance at 340nm, which actually
reflects the pyruvate-dependent decrease in concentration of NADH but is attributed to the
activity of LDH present in the sample. NADH concentrations decrease as LDH catalyzes the
reaction of pyruvate to lactate with conversion of one NADH to NAD+. LDH levels are
measured in both cell supernatant and cell lysate and normalized to protein concentration per
sample as determined by Bio-Rad Protein Assay.

LDH Determination
A confluent flask of Ishikawa cells was placed in EFBM 24 hours prior to beginning the
experiment. The following day cells were plated at 1.3 x 106 cells/well into CoStar 6-well plates
and allowed to adhere for 24 hours. Cells were treated with 0, 0.1mM, 0.3mM, 1.0mM, 10mM
and 20mM APAP, and then assayed at 24 and 96 hours. At the end of the incubation period cell
supernatant was removed for determination of LDH released by cells. Supernatant (400µl) was
added to 510µl LDH prep buffer (0.2M potassium phosphate pH 7.3), 30µl 10mM Na Pyruvate,
60µl 2mM NADH (1.42mg/ml 0.1 M potassium phosphate). To disrupt cells and release
intracellular LDH, 1ml 0.1% Triton X-100 was added to each well, cells were scraped off the
well by cell scraper and pipetted several times to completely disrupt cell membranes, creating a
cell lysate. To determine intracellular LDH activity 20µl of cell lysate were added to 890µl LDH
prep buffer (0.2M potassium phosphate pH 7.3), 30µl 10mM Na Pyruvate, 60µl 2mM NADH
(1.42mg/ml 0.1 M potassium phosphate). Absorbence was read at 5-second intervals for 60
seconds by continuous read with the spectrophotometer (Bausch and Lomb Spectronic 1001).
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Protein Concentration Determination
Bio-Rad Protein Assay is based upon the Bradford method, where an acidic dye binds
protein in solution (Bradford 1976). The Bio-Rad reagent dye changes color in response to
various concentrations of protein and binds primarily basic and aromatic amino acid residues,
especially arginine (Compton1985). The absorbance maximum for this protein bound dye occurs
at 595nm and is read with a spectrometer. Sample protein concentration is extrapolated by
comparison to a BSA standard curve. The microassay procedure was modified from the
manufacturer's protocol. For the protein standard curve, BSA was prepared at 2mg/ml and 8
dilutions were made in the range of 25µg-2,000µg protein. Cell lysate samples were diluted 1:10
in deionized H2O. In a CoStar 96-well plate 160µl of diluted sample or standard plus 40µl of
concentrated Bio-Rad reagent were added to wells in triplicate. Plates were incubated for 5
minutes at room temperature, and then absorbance was measured at 595nm with a spectrometer.
Protein concentration per 160 µl was extrapolated from absorbence value using the BSA
standard curve; protein per well was calculated with the following equation:

Example Calculation:
X µg protein/well = (µg protein extrapolated from standard curve)x(1000µl total sample volume/160µl)
x(10 dilution factor)
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Effect of Acetaminophen (APAP) on Alkaline Phosphatase Enzyme Activity
The purpose of this assay was to determine if APAP interacts directly with alkaline
phosphatase enzyme, altering its activity. Ishikawa cells were trypsinized, diluted to
2.6x105cells/ml and 8ml of suspension were added to six 100mm petri dishes. Cells were
incubated for 24 hours at 37°C, 5% CO2. Three plates were treated with 2ml of estradiol solution
(3µl 10mM E2 in 6ml EFBM) for a final concentration of 1nM estradiol to induce alkaline
phosphatase activity. Three control plates were dosed with 2ml of EFBM containing vehicle (3µl
EtOH in 6ml EFBM) and incubated for 72 hours. Medium was removed and plates rinsed twice
with PBS. Cells were removed using 0.5ml PBS and a cell scraper, then pipetted into 15ml tubes
on ice to achieve a final volume of 1.5ml suspended cells. Cells were lysed by sonication and
used for enzyme activity assay and Bio-Rad protein assay.
A concentration-response curve determined that 5µl of cell lysate produced alkaline
phosphatase activity within a linear range. In a 96-well plate, 5µl cell lysate, 25µl of APAP
solution and 50µl of substrate (para-nitrophenol phosphate) were added to wells in triplicate.
Estradiol-induced cell lysate was exposed to 2.5, 1.0, 0.5 or 0.25mM APAP. Alkaline
phosphatase activity was measured as change in absorbance at 405nm as previously described.

Fluorescence Microscopy: Calcein Staining
The purpose of this experiment was to examine live Ishikawa cells for visible
morphological changes after treatment with estradiol and APAP combination. The LIVE/DEAD
Viability/Cytotoxicity Assay Kit (Molecular Probes) contains a cell-permeant non-fluorescent
calcein AM which is enzymatically converted by intracellular esterases to an impermeable
intense green-fluorescence calcein at 495nm excitation, 515nm emission. While live cells have
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this endogenous esterase activity, dead cells do not. Nonviable cells may have esterase activity
present; however, due to compromised cellular membranes they are unable to retain the
converted fluorescent product. The method used was adopted from the Fluorescent Microscopy
Protocol provided by the manufacturer. Ishikawa cells in EFBM were plated in CoStar 24-well
plates at 3x104 cells/ml in 1ml aliquots and allowed to adhere to the plates for 24 hours. Cells
were treated the next day with 1nM estradiol plus 0, 0.03, 0.1, 0.3, or 1mM APAP and incubated
for 72 hours. Control cells were treated with media only. EthD-1 solution (4uM) was prepared
from the 2mM EthD-1 stock solution (20µl EthD-1, 10ml PBS). Media was removed from cells
and one ml of dye solution added. Cells were incubated at room temperature for 30 minutes.
Cells were viewed and photographed by fluorescent microscopy using a fluorescent filter at
485nm excitation, 530nm emission at 80X magnification.

Statistics
Statistical analysis of alkaline phosphatase activity, protein concentration and LDH
experiments were done by One-Way or Two-Way ANOVA followed by the Tukey’s Test when
significant differences (p<0.5) between group means were detected.
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Results
Estradiol Induction of Alkaline Phosphatase in Ishikawa Cells
Previous studies have demonstrated that Ishikawa cells have estrogen-responsive alkaline
phosphatase activity that responds maximally at 10-8M E2, with the highest activity reached 96
hours after E2 addition (Holinka et al., 1986). To ensure that this system was working
appropriately in our hands, an E2-concentration-response curve for alkaline phosphatase activity
in Ishikawa cells was performed. Cells were treated with 0.003-81nM estradiol as described in
methods; control cells were treated with media only. Results (Fig.5) show that alkaline
phosphatase activity was induced in a concentration-dependent manner with concentrations of
0.01-81nM E2 producing activity significantly higher than control. Maximal induction of alkaline
phosphatase activity, ~5-fold higher than control, was achieved at 0.3, 1 and 3nM E2, followed
by an apparent decline at 9, 27 and 81nM E2.
The amount of total cellular protein in cultures was also determined as described in
methods. Results shown in Fig.6 indicate that estradiol increased protein ~1.5-fold above control
at 0.003, 0.01, 0.03, 0.1, 0.3, and 3nM E2 while 1, 9, 27 and 81nM E2 did not significantly alter
protein levels. Although cell protein did increase at some concentrations of E2, this did not occur
in a concentration-dependent manner nor was it near the magnitude of increase in the alkaline
phosphatase activity measured at corresponding E2 concentrations. These experiments
demonstrate that estradiol induced alkaline phosphatase activity in Ishikawa cells and that this
increase in activity was only partly attributed to an increase in total cellular protein.
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Acetaminophen Inhibits Basal Alkaline Phosphatase activity in Ishikawa Cells
Previous studies in our laboratory have shown that APAP induced cell proliferation in
ER+ MCF-7 breast cancer cells and that antiestrogens inhibit APAP-induced proliferation
(Harnagea-Theophilus et al., 1998). It was hypothesized that APAP would have a similar
stimulatory effect on estrogen-inducible alkaline phosphatase activity in Ishikawa cells. Cells
were treated as described with 0.03, 0.1, 0.3, or 1mM APAP; control cells were treated with
media alone. The concentrations of APAP chosen corresponded with the previous studies
conducted with MCF-7 cells (Harnagea-Theophilus et al., 1998). Results in Fig.7 show that
APAP did not induce alkaline phosphatase, rather, APAP significantly inhibited basal levels of
alkaline phosphatase activity ~50% compared to control cells. Levels of alkaline phosphatase
activity among APAP treated groups were not significantly different from one another. This
experiment was repeated 3 more times for a total of 4 experiments, all with the same results. In
two of four experiments, 0.3 and 1mM APAP treatment decreased total cellular protein 20% and
60% respectively, relative to control cells (Fig. 8). In the other two experiments, total cellular
protein was not significantly altered by APAP (not shown).
Results from this experiment do not support the initial hypothesis that APAP would
increase estrogen-inducible alkaline phosphatase in Ishikawa cells. Acetaminophen decreases
basal levels of alkaline phosphatase activity and this effect may be in part due to decreases in
total cellular protein at 0.3 and 1mM APAP concentrations.

Acetaminophen Inhibits Estradiol-Induced Alkaline Phosphatase
The purpose of the next experiment was to determine if APAP would have the same
inhibitory affect upon estradiol-induced alkaline phosphatase activity as it did on the basal
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enzyme activity. Cells were treated with 1nM E2 plus 0.03, 0.1, 0.3, or 1mM APAP; control cells
were treated with media only. The concentration of 1nM E2 was chosen because it induced a
strong yet submaximal alkaline phosphatase activity (Fig. 5). Results (Fig.9) show that 1nM E2
induced alkaline phosphatase activity ~9-fold above control level and that 0.1, 0.3, 1mM APAP
inhibited this activity by 29%, 62% and 91%, respectively. The effects of E2 and APAP on total
protein levels (Fig.10) show that estradiol (1nM) alone had no significant effect on protein
concentration, while the combination of 1nM E2 plus 0.3 or 1mM APAP significantly decreased
protein concentration compared to both control and 1nM E2; protein concentrations decreased 35
and 70%, respectively, compared to 1nM E2. These data are representative of 4 experiments.
These experiments indicate that APAP inhibits estradiol-induced alkaline phosphatase
activity in a concentration-dependent manner at 0.1, 0.3 and 1mM concentrations.
Acetaminophen also decreases estradiol-induced protein concentrations at 0.3 and 1mM
significantly lower than both control and estradiol-treated cells, suggesting that it may be toxic at
these levels.

Lactate Dehydrogenase Cytotoxicity Assay
In order to determine if cytotoxicity was playing a role in APAP’s inhibitory effect on
E2-induced alkaline phosphatase activity, a lactate dehydrogenase (LDH) release assay was
conducted, which is a well-characterized marker of cell cytotoxicity (Ray et al., 2000). Ishikawa
cells were plated and treated with 0.1, 0.3, 1, 10 or 20mM APAP; control cells were treated with
media alone. High APAP concentrations (10 and 20mM) were used in this study as positive
controls for toxicity. Intracellular LDH activity obtained from cell lysate and LDH activity
released into medium were determined after 24 and 96-hours of exposure as shown in Table 1;
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intracellular and released LDH activity were normalized to total cellular protein as obtained from
cell lysate. Total LDH activity was the sum of intracellular and released LDH activity.
Percentage released from total LDH expresses the amount of LDH activity released into the
media as a percentage of the total LDH per well.
After 24-hours cells treated with 0.3, 1, 10 and 20mM APAP showed a decline in
intracellular LDH activity. Released LDH activity increased slightly when cells were exposed to
1 and 20mM APAP; 10mM APAP-treated cells released LDH almost 4-times higher than control
but this effect was not reproducible. This indicates that after 24-hours there is little toxicity in
Ishikawa cells exposed to APAP at the concentrations tested. By 96-hours LDH release increased
dramatically in cells treated with 1, 10 and 20mM APAP compared to control; LDH release
increased to a lesser degree in 0.3mM APAP-treated cells. Intracellular LDH remained lower in
0.3, 1, 10 and 20mM APAP-treated cells compared to control. In summary, after 96-hours of
exposure Ishikawa cells may show signs of toxicity with 0.3mM APAP treatment, and at 1, 10
and 20mM APAP toxicity is apparent.
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Table 1. Effect of APAP on LDH Release from Ishikawa Cells
Control

0.1mM

0.3mM

1mM

10mM

20mM

1.49
1.46
0.03
2%

1.43
1.41
0.02
1.4%

1.16
1.14
0.02
1.7%

1.09
1.06
0.03
2.8%

1.03
0.95
0.08
7.8%

1.22
1.18
0.04
3.3%

2.05
1.97
0.08
3.9%

2.33
2.24
0.09
3.9%

1.90
1.76
0.14
7.4%

1.16
0.91
0.25
21.6%

1.09
0.89
0.20
18.4%

0.84
0.47
0.37
44.1%

24-hours
Total LDH*
Intracellular*
Released*
% released of total
LDH

96-hours
Total LDH*
Intracellular*
Released*
% released of total
LDH

Table 1. Cells were treated with 0.1, 0.3, 1, 10 or 20mM APAP and assayed for LDH
activity at 24 and 96-hours. Following exposure period, media removed from cells was assayed
for released LDH activity and cell lysate was prepared and assayed for intracellular LDH activity
and total cellular protein. Intracellular represents total cellular LDH activity (*∆Abs340nm/min/mg
total cellular protein); released LDH represents total LDH activity released into medium
(*∆Abs340nm/min/mg total cellular protein); total LDH is the sum of intracellular and released
LDH. Percentage of total LDH released expresses the amount of LDH activity released into the
media as a percentage of the total LDH per well. While treatment with APAP for 24-hours did
not affect LDH release, after 96-hours there was an increase in %LDH release in 0.3, 1, 10 and
20mM APAP-treated cells indicating cytotoxicity.

Alkaline Phosphatase Enzyme Is Not Directly Inhibited By Acetaminophen
The next experiment was designed to determine if APAP directly inhibits alkaline
phosphatase enzyme activity. Cells were plated, treated with estradiol to induce alkaline
phosphatase and a cell lysate containing alkaline phosphatase was prepared as described in
methods. Alkaline phosphatase assays were conducted in the absence (control) or presence of
0.25. 0.5, 1.0 or 2.5mM APAP. Alkaline phosphatase specific activity (abs405nm/min/µg prot) was
determined and is presented in Table 1. Results from this experiment indicate that none of the
APAP concentrations tested directly inhibit the enzymatic activity of alkaline phosphatase.
Experiment was done in duplicate with analogous results.
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Table 2. Effect of APAP on Alkaline Phosphatase Enzyme Activity
Control

0.81

0.25mM APAP

0.85

0.5mM APAP

0.85

1.0mM APAP

0.98

2.5mM APAP

0.89

Table 2. Ishikawa cell lysate containing estradiol-induced alkaline phosphatase was
treated with 0.25, 0.5, 1.0 or 2.5mM APAP and assayed for enzyme activity. Specific
activity*(∆Abs340nm/min/mg total cellular protein) of estradiol-induced alkaline
phosphatase enzyme was not altered by addition of APAP.
Effects of Varying Concentrations of E2 and APAP on Alkaline Phosphatase Activity and
Protein Concentration
The next set of experiments was designed to determine if the degree of APAP inhibition
of alkaline phosphatase activity was affected by the concentration of E2 (Table 3). Cells were
treated with either 0.01, 0.1 or 1nM E2 in combination with 0, 0.03, 0.1, 0.3, or 1mM APAP;
control cells were treated with media only. At 1mM APAP, E2-induced alkaline phosphatase
activity decreased approximately 77% at all E2-concentrations examined. Inhibition of estradiolinduced alkaline phosphatase activity at 0.3mM APAP ranged from 16% to 34% and was not
dependent on the concentration of E2. At 0.1 and 0.03mM APAP, estradiol-induced alkaline
phosphatase activity was not significantly inhibited. Furthermore, alkaline phosphatase activity
was significantly increased in Ishikawa cells treated with 0.01nM E2 plus 0.03mM APAP.
Results shown in Table 3 indicate that APAP inhibition of estradiol-induced alkaline
phosphatase activity does not change significantly with increasing concentrations of estradiol.
Protein concentrations were decreased at all estradiol concentrations with 1mM APAP, and less
dramatically at 0.3mM APAP. Treatment with 0.1 or 0.03mM APAP had little, if any, effect on
protein concentrations at 0.01 and 1nM E2; 0.01nM E2 showed slightly lower protein
concentrations for all APAP treatments, compared to the other two estradiol-treatment groups.
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There is some similarity between trends in decreased estradiol-induced alkaline
phosphatase activity and protein concentrations in response to different concentrations of APAP.
However, the magnitude of inhibition of estradiol-induced alkaline phosphatase activity is not
equivalent to the decrease in protein for the majority of treatment groups. APAP (1mM )
substantially decreased E2-induced alkaline phosphatase activity relative to protein
concentrations. Increased estradiol-induced alkaline phosphatase activity at 0.03 and 0.1mM
APAP does not correlate to protein data, as protein concentrations decrease slightly or do not
change compared to controls. Cells treated with 0.3mM APAP plus 0.01, 0 .1 or 1nM E2 showed
some similarity between alkaline phosphatase activity and protein levels. These results indicate
that APAP does affect cellular protein concentrations of estradiol-treated Ishikawa cells;
however, this is not always equal to the magnitude of the effect APAP appears to have on
estradiol-induced alkaline phosphatase activity. Therefore, it appears that APAP reduces
estradiol-induced alkaline phosphatase activity more than it reduces cellular protein, and this
effect does not change with increasing concentrations of E2.
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Table 3. Changes in alkaline phosphatase activity and protein concentration with
varying combinations of E2 and APAP
E2-induced Alkaline Phosphatase Activity % of E2 control
0.03mM APAP 0.1mM APAP 0.3mM APAP
137 + 18.6
115 + 9.5
70.5 + 3.3
0.01nM E2
109.8 + 10.8
83.5 + 7.0
91.3 + 12.1
0.1nM E2
106.8 + 4.2
90.8 + 6.9
65.5 + 9.5
1nM E2
Total Protein % of E2 control
0.03mM APAP
92.0 + 6.7
0.01nM E2
87.8 + 8.6
0.1nM E2
90.8 + 15.1
1nM E2

0.1mM APAP
99.6 + 6.7
79.3 + 5.5
92.8 + 8.2

0.3mM APAP
76.8 + 8.5
68.8 + 18.4
83.3 + 8.7

1mM APAP
22.5 + 3.7
23.3 + 3.6
23.5 + 6.4
1mM APAP
79.2 + 13.4
43.3 + 15.8
59.3 + 28.6

Cells were plated in 96-well plates and exposed to varying concentrations of E2 and APAP. After 96hours incubation with test compounds, individual wells were assayed for alkaline phosphatase activity
or protein concentration by fluorescamine. Results shown are the mean of 4 experiments, with
individual treatment group data expressed as percent of activity or protein concentration compared to
the corresponding estradiol-only treatment group (100%) from that experiment. Control cells treated
with media were used to indicate induction of alkaline phosphatase activity by E2 (not shown). Results
show that increasing concentrations of E2 did not significantly alter the effect of APAP on alkaline
phosphatase or protein concentrations at the various concentrations tested. Standard error is shown.

APAP Amplifies Antiestrogen Effects in Ishikawa Cells
The next study tested the hypothesis that APAP would enhance the inhibitory effect of
antiestrogens on E2-induced alkaline phosphatase. Previous studies demonstrated antiestrogens
inhibit E2-induced alkaline phosphatase activity in Ishikawa cells (Holinka et al.,1986; Simard et
al.,1997; Littlefield et al.,1990). Cells were treated with 0.1nM E2 in combination with 0.01, 0.1,
1 or 10µM 4-hydroxy tamoxifen (OHT) (Sigma) or ICI 182,780 (Zeneca Pharmaceuticals);
control cells were treated with media only. Concentrations of anti-estrogens were chosen based
upon current literature (Holinka et al.,1986; Simard et al.,1997; Littlefield et al.,1990). The
concentration of 0.1nM E2 was chosen because it induced submaximal alkaline-phosphatase
activity within the linear range. Results shown are representative of experiments done in
triplicate. Treatment with 0.01, 0.1, or 1µM OHT inhibited E2-induced alkaline phosphatase
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activity ~45% from 1nM E2-treated cells (Fig.11), with no significant differences between
alkaline phosphatase activity of the different OHT treatment groups, while 10µM OHT
eliminated E2-induced alkaline phosphatase activity completely. Fig.12 shows that OHT had no
significant effect on cellular protein concentrations except at 10µM where protein declined to
almost zero, indicating a toxic effect., In one of the two experiments 0.01µM OHT decreased
protein 32% compared to 1nM E2, but this data was inconsistent with the other data.
Results in Fig.13 show that ICI 182,780 inhibits E2-induced alkaline phosphatase activity
95% relative to cells treated with 1nM E2 alone. Fig.14 shows an ICI 182,780 concentrationdependent decrease in cellular protein, with 0.1, 1 and 10µM ICI resulting in 27%, 36% and 61%
decrease, respectively. Results for both antiestrogens shown are representative of two separate
experiments with similar results.
The next part of this experiment was to examine the effect of APAP in combination with
OHT, on E2-induced alkaline phosphatase. Cells were plated and treated as described in methods
with either 0.1nM E2, 0.1nM E2 + 0.01µM OHT, or 0.1nM E2 + 0.01µM OHT + 0.03, 0.1, 0.3 or
1mM APAP. The concentration 0.01µM OHT was chosen because it was the lowest
concentration that produced significant inhibition of 0.1nM E2-induced alkaline phosphatase
activity. Results (Fig.15) show that 0.1nM E2 induced alkaline phosphatase activity ~7.5-fold,
and this was decreased ~65% by 0.01µM OHT. Addition of 0.1, 0.3 and 1mM APAP enhanced
this inhibition of activity by an additional 38%, 71% and 90% compared to OHT alone. Protein
concentrations (Fig.16) were doubled by 0.1nM E2 compared to control and were unaffected by
addition of 0.01µM OHT alone. Addition of 0.3 and 1mM APAP decreased protein
concentrations 36% and 73% compared to E2 plus OHT alone, while lower concentrations
produced no significant effect. Again, although APAP produced a significant decrease in cellular
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protein concentrations in some treatment groups, the effectsproduced do not account for the total
reduction of enzyme activity.

Fluorescent Microscopy
Calcein fluorescent staining was utilized to show morphological changes in live Ishikawa cells in
response to E2 and APAP treatments (Fig.17). Cell permeant non-fluorescent calcein is
enzymatically converted to an impermeable green-fluorescent product by esterases and retained
in the cell. Results show that Ishikawa cells in the control group grow in large clusters adhered to
the plate with individual cells well defined. 1nM E2-treated cells appear similar to those of
control. Cells treated with 1nM E2 + 0.03mM APAP do not appear drastically altered, but
clusters of cells are smaller. Cells treated with 1nM E2 + 0.1mM, or 0.3mM APAP appear more
misshapen and there are less cells in the particular fields photographed. Ishikawa cells treated
with 1nM E2 + 1mM APAP were distorted and most cells no longer adhered to the plate,
indicating toxicity.
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Fig.5. Estradiol induces alkaline phosphatase activity in Ishikawa cells. Cells were plated in
96-well plates and exposed to 0.003-81nM E2 for 96-hours, then assayed for alkaline
phosphatase activity. Alkaline phosphatase was induced in a concentration-dependent manner
with maximal activity at 1nM E2, approximately 5-fold higher than control levels. Each point
represents the mean + standard error of five individual wells from a single experiment; a total of
four experiments were conducted with similar results. *Activity increased significantly
compared to control (p<0.05).
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Fig.6. Estradiol increases total cellular protein concentrations in Ishikawa cells. Cells were
plated in 96-well plates and exposed to 0.003-81nM E2 for 96-hours, then assayed for total
cellular protein by fluorescamine assay. Protein concentrations increased 1.5-fold with 0.0030.3nM E2-treatment, but not in a concentration-dependent manner. Each point represents the
mean + standard error of four individual wells from a single experiment; a total of four
experiments were conducted with similar results. *Protein concentration increased significantly
compared to control (p<0.05).
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Fig.7. Acetaminophen (APAP) inhibits basal alkaline phosphatase activity in Ishikawa
cells. Cells were plated in 96-well plates and exposed 0.03, 0.1, 0.3, and 1mM APAP for 96hours, then assayed for alkaline phosphatase activity. Alkaline phosphatase was significantly
inhibited by APAP treatment at all concentrations tested compared to control cells. Each point
represents the mean + standard error of five individual wells from a single experiment; a total of
four experiments were conducted with similar results. *Activity decreased significantly
compared to control (p<0.05).
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Fig.8. Acetaminophen (APAP) decreases total cellular protein in Ishikawa cells. Cells were
plated in 96-well plates and exposed 0.03, 0.1, 0.3, and 1mM APAP for 96-hours, then assayed
for total cellular protein by fluorescamine assay. Protein concentrations were unaffected by
treatment with 0.03 and 0.1mM APAP, but were significantly decreased by 0.3 and 1mM APAP
compared to control. Each point represents the mean + standard error of four individual wells
from a single experiment; a total of four experiments were conducted with similar results.
*Protein concentration decreased significantly compared to control (p<0.05).
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Fig.9. Acetaminophen (APAP) inhibits E2-induced alkaline phosphatase activity in
Ishikawa cells. Cells were plated in 96-well plates and exposed to 1nM E2, or a combination of
1nM E2 and 0.03, 0.1, 0.3, 1mM APAP for 96-hours, then assayed for alkaline phosphatase
activity. Alkaline phosphatase was induced by 1nM E2; combinations of 1nM E2 and 0.1, 0.3,
and 1mM APAP had significantly decreased alkaline phosphatase activity compared to 1nM E2
alone. This inhibition of activity increased with increasing concentrations of APAP. Cells treated
with 1nM E2+1mM APAP had alkaline phosphatase activity decreased below control levels.
Each point represents the mean + standard error of five individual wells from a single
experiment; a total of four experiments were conducted with similar results. *Activity increased
significantly compared to control (p<0.05). #Activity decreased significantly compared to 1nM
E2 (p<0.05).
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Fig.10. Acetaminophen (APAP) decreases total cellular protein concentrations in E2treated Ishikawa cells. Cells were plated in 96-well plates and exposed to 1nM E2, or a
combination of 1nM E2 and 0.03, 0.1, 0.3, 1mM APAP for 96-hours, then assayed for total
cellular protein by fluorescamine assay. While 1nM E2 alone had no effect on protein
concentration, combination of 1nM E2 and 0.3, or 1mM APAP significantly decreased total
cellular protein in comparison to control. Each point represents the mean + standard error of four
individual wells from a single experiment; a total of four experiments were conducted with
similar results. *Protein concentration decreased significantly compared to control (p<0.05). #
Protein concentration decreased significantly compared to 1nM E2 (p<0.05).
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Fig.11. Tamoxifen inhibits E2-induced alkaline phosphatase activity in Ishikawa cells. Cells
were plated in 96-well plates and exposed to 1nM E2, or a combination of 1nM E2 and 0.01, 0.1,
1, 10µM OHT for 96-hours, then assayed for alkaline phosphatase activity. OHT significantly
decreased alkaline phosphatase activity by ~50% in cells treated with 1nM E2 and 0.01, 0.1 µM
OHT; there was no detectable activity in cells treated with 1nM E2 plus 10µM OHT. Each point
represents the mean + standard error of five individual wells from a single experiment; a total of
four experiments were conducted with similar results. *Activity significantly different from
control (p<0.05). #Activity decreased significantly compared to 1nM E2 (p<0.05).
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Fig.12. Tamoxifen decreases total cellular protein concentrations in E2-treated Ishikawa
cells. Cells were plated in 96-well plates and exposed to 1nM E2, or a combination of 1nM E2
0.01, 0.1, 1, 10µM OHT for 96-hours, then assayed for total cellular protein by fluorescamine
assay. Treatment with 1nM E2 or combination of 1nM E2 0.01, 0.1, 1µM OHT had no effect on
cellular protein concentrations compared to control, however, 1nM E2 plus 10µM OHT
decreased protein levels to almost zero indicating toxicity. Each point represents the mean +
standard error of four individual wells from a single experiment; a total of four experiments were
conducted with similar results. *Protein concentration decreased significantly compared to
control (p<0.05). # Protein concentration decreased significantly compared to 1nM E2 (p<0.05).
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Fig.13. Anti-estrogen ICI 182,780 inhibits E2-induced alkaline phosphatase activity in
Ishikawa cells. Cells were plated in 96-well plates and exposed to 1nM E2, or a combination of
1nM E2 and 0.01, 0.1, 1, 10µM ICI 182,780 for 96-hours, then assayed for alkaline phosphatase
activity. Estradiol-induced alkaline phosphatase activity decreased significantly and below
control levels in cells treated with combinations of 1nM E2 and ICI 182,780; there was no
significant difference in the activity between anti-estrogen treatment groups. Each point
represents the mean + standard error of five individual wells from a single experiment; a total of
four experiments were conducted with similar results. *Activity significantly different from
control (p<0.05). #Activity decreased significantly compared to 1nM E2 (p<0.05).
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Fig.14. Anti-estrogen ICI 182,780 decreases total cellular protein concentrations in E2treated Ishikawa cells. Cells were plated in 96-well plates and exposed to 1nM E2, or a
combination of 1nM E2 and 0.01, 0.1, 1, or 10µM ICI 182,780 for 96-hours, then assayed for
total cellular protein by fluorescamine assay. Treatment with 1nM E2 had no effect on cellular
protein concentrations compared to control, however, 1nM E2 plus 0.01, 0.1, 1, 10µM ICI
182,780 significantly decreased protein in a concentration-dependent manner with increasing
concentration of ICI 182,780. *Protein concentration decreased significantly compared to control
(p<0.05). # Protein concentration decreased significantly compared to 1nM E2 (p<0.05).
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Fig.15. Acetaminophen (APAP) amplifies tamoxifen inhibition of E2-induced alkaline
phosphatase activity in Ishikawa cells. Cells were plated in 96-well plates and exposed to 1nM
E2, 1nM E2 plus 0.01µM OHT, or combination of 1nM E2 and 0.01µM OHT and 0.03, 0.1, 0.3 or
1mM APAP for 96-hours, then assayed for alkaline phosphatase activity. Treatment with 1nM E2
plus 0.01µM OHT inhibited E2-induced alkaline phosphatase activity and this inhibition
significantly increased with the addition of 0.1, 0.3 and 1mM APAP compared to 1nM E2 plus
0.01µM OHT alone. *Activity significantly different from control (p<0.05). #Activity decreased
significantly compared to 1nM E2 (p<0.05). +Activity decreased significantly compared to 1nM
E2 + 0.01µM OHT (p<0.05).
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Fig.16. Acetaminophen (APAP) decreases total cellular protein concentrations in E2-OHT
treated Ishikawa cells. Cells were plated in 96-well plates and exposed to 1nM E2, 1nM E2 plus
0.01µM OHT, or combination of 1nM E2 and 0.01µM OHT and 0.03, 0.1, 0.3 or 1mM APAP for
96-hours, then assayed for total cellular protein by fluorescamine assay. Treatment with 1nM E2
increased total cellular protein significantly compared to control; treatment with 1nM E2 plus
0.01µM OHT increased total cellular proteins compared to control but was not significantly
different than E2-treated cells. Treatment with E2 plus OHT and 0.3 or 1mM APAP decreased
protein concentrations significantly below E2 plus OHT-treated cells. Each point represents the
mean + standard error of four individual wells from a single experiment; a total of four
experiments were conducted with similar results. *Protein concentration significantly different
from control (p<0.05). # Protein concentration decreased significantly compared to 1nM E2
(p<0.05). + Protein concentration decreased significantly compared to 1nM E2 + 0.01µM OHT
(p<0.05).
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Fig.17. Calcein staining of Ishikawa shows morphological changes in response
Acetaminophen (APAP) treatment. Cells were plated in 24-well plates and exposed to E2, and
E2 plus 0.03, 0.1, 0.3 1mM APAP for 96-hours. Calcein (M) was added to each well and cells
were examined using fluorescent microscopy with 80X magnification. Treatment with E2 had no
visible effect; treatment with E2 plus 0.03, 0.1mM APAP decreased size of clusters of cells; cells
treated with E2 plus 0.3mM APAP appear misshapen; cells treated E2 plus 1mM APAP are no
longer attached to plate indicating toxicity.
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Discussion
Acetaminophen (APAP) is currently being investigated as a possible endocrine disruptor
due to its ability to alter estrogenic responses in vitro. At therapeutic concentrations, APAP
induced cell proliferation in ER+/PR+ MCF-7 and T47D breast cancer cells and this effect was
successfully inhibited by addition of antiestrogens; there was no induction of cell proliferation in
ER-/PR- breast cancer cells (Harnagea-Theophilus et al., 1998). Another study demonstrated
APAP inhiibted estrogen-dependent vitellogenin production in trout liver cells in vitro (Miller et
al., 1999). However, most significant to human health issues are the case studies suggesting that
APAP use is associated with decreased ovarian cancer incidence and alteration in hormone
levels, including estrogen, in women who take the drug (Cramera,b et al., 1998).
The initial hypothesis was that APAP would induce estrogen-responsive alkaline
phosphatase activity in Ishikawa endometrial cells based upon studies that indicate APAP has
estrogen-like activity on cell proliferation in ER+/PR+ breast cancer cells (Harnagea-Theophilus
et al., 1998). In order to test this hypothesis, Ishikawa cells were cultured in 96-well plates and
exposed to 0.03, 0.1, 0.3 or 1mM APAP for 96-hours based upon the microtiter assay described
by Littlefield et al. (1990). Acetaminophen concentrations were based upon those used in MCF-7
proliferation studies by Harnagea-Theophilus et al. (1998). Alkaline phosphatase activity and
total cellular protein concentration were determined for APAP-treated cultures and controls.
Total cellular protein was determined in addition to enzyme activity in order to have a variable
comparable to enzyme activity; significant changes in protein concentration could be interrelated
to increases in enzyme activity.
Acetaminophen decreased estrogen-responsive alkaline phosphatase activity in Ishikawa
endometrial carcinoma cells, and thus the initial hypothesis was not borne out. Acetaminophen
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(0.1, 0.3 and 1mM) significantly inhibited basal and 1nM E2-induced alkaline phosphatase
activity; however, cellular protein concentrations were only inhibited by 0.3 and 1mM APAP
alone or in combination with 1nM E2. While the degree of enzyme inhibition was larger than the
degree of protein decrease, these effects could have been the result of APAP toxicity. LDH
release cytotoxicity assay was conducted to ensure that the decrease in alkaline phosphatase
activity was not due to APAP toxicity. Ishikawa cells were exposed to 0.1, 0.3, 1, 10 or 20mM
APAP for 24 and 96 hours and then assayed for LDH release. While toxicity was not detected at
24-hours, after 96-hours Ishikawa cells exposed to 1, 10 and 20mM APAP did release a
considerable percentage of LDH thus indicating cytotoxicity.
Fluorescent microscopy results (Fig. 17) support the conclusion that 1mM APAP is toxic
to Ishikawa cells; cells are visibly misshapen and unattached to the plate. This suggests that
inhibition of alkaline phosphatase by 1mM APAP, with or without 1nM E2, is likely due to
APAP-toxicity. Cells exposed to 0.3mM APAP also had an increase in LDH release, but to a
lesser degree than 1mM-treated cells while 0.1mM APAP had no effect on LDH release.
Treatment with 0.3mM APAP significantly inhibited alkaline phosphatase activity and
significantly decreased protein concentrations, observations that may be due to toxicity. Alkaline
phosphatase inhibition by 0.1mM APAP was not accompanied by any effect on protein and
cannot be correlated to any toxic effect of APAP. Therefore, the inhibitory effect of APAP on
alkaline phosphatase activity may be due partially to toxicity at 0.3, and 1mM APAP
concentrations; however, there is still a level of inhibition that exists in cells treated with 0.1mM
APAP that remains unexplained.
The next question to be addressed was a determination of any direct inhibition of
alkaline phosphatase enzyme activity by APAP. Results of the alkaline phosphatase enzyme
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specific activity assay (Table 1) indicate that at the concentrations tested, APAP had no effect on
enzyme activity compared to control. In conclusion, APAP inhibits basal and E2-induced alkaline
phosphatase activity and this is not due to direct enzyme inhibition.
The second hypothesis determined if increasing concentrations of E2 would decrease
APAP inhibition of alkaline phosphatase activity. Cells were treated with 0.03, 0.1, 0.3 or 1mM
APAP plus either 0.01, 0.1 or 1nM E2; samples were then assayed for alkaline phosphatase
activity and cellular protein. Results (Table 2) show that APAP inhibition was not affected by
different concentrations E2. The level of inhibition by a single concentration of APAP was not
significantly changed when estradiol was increased 10 or even 100-fold; protein concentrations
were unaffected under the same conditions. There were no signs of competitive inhibition by
APAP on E2-induced alkaline phosphatase activity. The results from this inhibition study are in
agreement with studies that indicate APAP does not compete with E2 for binding at ER (Miller et
al., 1999; Isenhower et al., 1986; Harnagea-Theophilusa et al., 1999).
Interestingly, cells treated with 0.01nM E2 plus 0.03 or 0.1nM APAP had a stimulatory
effect and significantly increased alkaline phosphatase activity compared to 0.01nM E2 alone.
This effect was seen in 3 of the four experiments conducted and there were no changes cellular
protein, suggesting that APAP may have some partial-agonist activity when combined with
0.01mM E2.
In the E2-APAP inhibition study (Table 3) it appears that APAP had less of an inhibitory
effect upon 1nM E2-induced alkaline phosphatase activity than indicated in initial studies (Fig.
7). This is a result of expressing the data as a mean of four experiments rather than showing a
single representative experiment. There was some variation in the magnitude of response in both
alkaline phosphatase and protein concentration within the four experiments conducted.
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Variability resulted from Ishikawa cells being cultured in estradiol-free medium for a minimum
of two weeks prior to an experiment in order to achieve low basal levels of alkaline phosphatase
activity. Cells were viable for a period of approximately six-weeks under estrogen-free
conditions, and had the highest levels of enzyme activity and protein concentration after the
initial two-week staging period. Maximal activity and protein concentration in response to E2
declined slightly with time; however, the relative percent of inhibition by APAP did not change.
This is indicated by relatively low standard error between experiments (Table 3).
Based upon the inhibitory effect of APAP on alkaline phosphatase determined in prior
experiments, the final hypothesis of this study tested the ability of APAP to increase the
inhibitory effect of antiestrogens on alkaline phosphatase activity in Ishikawa cells. Antiestrogen
ICI 182,780, a type I pure antiestrogen, has been shown to inhibit 1nM E2 -induced alkaline
phosphatase activity in a concentration-dependent manner (Markiewicz et al., 1997); however, in
the present study 0.01-10µM ICI 182,780 significantly inhibited E2 -induced alkaline
phosphatase activity below controls levels (Fig. 13) and was therefore deemed unsuitable for this
study.
4-Hydroxy tamoxifen is a type II antiestrogen with partial agonist activity in Ishikawa
cells, although published reports are not consistent at this point. While some studies indicate that
OHT alone weakly stimulates alkaline phosphatase activity (Simard et al., 1997; Anzai et al.,
1989, Markiweicz et al., 1997), cell growth (Anzai et al., 1989), and significantly inhibits E2 induced alkaline phosphatase activity (Simard et al., 1997; Holinka et al., 1986; Markiweicz et
al., 1997), another study (Albert et al., 1990) found that OHT had no effect on basal or E2 induced alkaline phosphatase activity.
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Results (Fig. 11) show that OHT alone decreased alkaline phosphatase activity ~50% at
0.01, 0.1 and 1µM; cellular protein concentrations were unaffected; however, at 10µM OHT
both alkaline phosphatase activity and protein concentrations were absent apparently due to
toxicity. As hypothesized, APAP increased OHT inhibition of E2 -induced alkaline phosphatase
activity (Fig. 15). While addition of 0.03APAP to 1nM E2 plus 1µM OHT had no effect (which
agrees with previous data), addition of 0.1, 0.3 and 1mM APAP significantly increased inhibition
of alkaline phosphatase activity in a concentration-dependent manner compared to E2 plus OHT
alone. Cellular protein levels were significantly decreased only in cells treated with E2 plus OHT
and 0.3, 1mM APAP. This study indicates that APAP potentiates the inhibitory effect of
antiestrogen OHT.
In summary, 0.01, 0.3 and 1mM APAP inhibits both basal and E2 -induced alkaline
phosphatase activity in Ishikawa endometrial cells. In combination with antiestrogen OHT,
APAP further inhibits E2-induced alkaline phosphatase activity. Cellular protein is significantly
decreased in cells treated with 0.3 and 1mM APAP alone, in combination with 1nM E2, or 1nM
E2 plus 1µM OHT. As determined by LDH release, APAP is toxic at 1mM, to a lesser degree at
0.5mM and not at all at 0.25 compared to control. Therefore, alkaline phosphatase activity
inhibition by 1mM APAP may be in part due to APAP-toxicity, but inhibition by 0.3 and 0.1mM
APAP is not due to toxicity. APAP has no inhibitory effect on the specific activity of E2 -induced
alkaline phosphatase.
The mechanism by which APAP inhibits alkaline phosphatase activity is unknown.
Estrogen induction of alkaline phosphatase enzyme activity in Ishikawa cells occurs via the
classical ER mediated pathway (Fig.18). Acetaminophen does not appear to be acting through a
traditional antiestrogenic mechanism as it does not compete with estradiol for binding at the ER
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(Miller et al., 1999; Isenhower et al., 1986; Harnagea-Theophilusa et al., 1999) or inhibit enzyme
activity directly. The fact that both basal and E2-inducible alkaline phosphatase enzyme activity
is inhibited suggests that APAP may be targeting the transcription or the translational processes.
This study did not address the question of the effect of APAP on the specific isozymes of
alkaline phosphatase. Acetaminophen inhibits estradiol-responsive alkaline phosphatase (Fig. 5),
but in addition, most likely inhibits the other isotypes as reflected in the inhibition of basal
enzyme activity under serum-free (estrogen-free) conditions (Fig.7).
A recent study demonstrated that aryl hydrocarbon receptor agonists inhibited estrogeninduced responses through AhR-ER crosstalk in Ishikawa cells (Wormke et al., 2000). The aryl
hydrocarbon receptor is known to be involved in the metabolism of xenobiotics; no endogenous
ligand has been identified. The AhR contains several transactivational domains that mediate
ligand-recognition/binding, DNA binding, AhR nuclear transport protein (ARNT) binding, as
well as cell-specific inhibitory protein binding domain (Ma Q et al., 1997). In target cells AhR
agonists, such as TCCD, bind the aryl hydrocarbon receptor and then complex with AhR nuclear
transport proteins while accumulating in the nucleus of the cell (Fig. 19). This complex binds
dioxin response elements (DREs), also known as xenobiotic response elements (XREs), and
results in transcription of genes involved in drug and hormone metabolism such as cytochrome
P4501A1 (CYP1A1), CYP1B1, GST, A2 and NADPH quinone reductase (Klinge et al., 1999).
Although the AhR-ARNT complex does not bind consensus estrogen-response elements, the
complex does bind naturally occurring EREs that contain XRE-like sequences, such as human cfos, pS2, and progesterone receptor gene promoter regions (Klinge et al., 1999). In transiently
transfected MCF-7 breast cancer cells, TCDD inhibited E2-activated reporter gene activity from
both consensus EREs and EREs from c-fos, pS2, and progesterone receptor genes (Klinge et al.,
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1999). This antiestrogenic activity by TCDD and other polycyclic hydrocarbon compounds is
termed AhR-ER crosstalk. TCDD and other AhR ligands do not bind the ER or displace E2 from
its receptor in ligand-binding studies (Klinge et al., 1999); however, unbound AhR directly
interacts with ERα (Klinge et al., 2000). The AhR has no interaction with ERβ and complexed
AhR/ARNT has no interaction with the ERα or β (Klinge et al., 2000). While the underlying
mechanism behind AhR-ER crosstalk is not completely understood, studies indicate that there is
direct interaction between the AhR and ER-mediated responses.
A recent study by Wormke et al. (2000) confirms that both AhR and ARNT protein are
expressed in Ishikawa cells. Inhibitory AhR-ER crosstalk was determined using E2-induced
proliferation and transcriptional assays in Ishikawa cells transfected with E2-responsive
constructs using promoters from the progesterone receptor or vitellogenin A2 genes. Aryl
hydrocarbon receptor agonists, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), benzo[a]pyrene
(BaP) and 6-methyl-1,3,8-trichlorodeibenzofuran, inhibited 32-47% of the E2 -induced responses
(Wormke et al., 2000). A second study using ECC-1 endometrial cancer cells, which express
ERα and AhR, found that treatment with TCCD also inhibited E2 -induced cell proliferation
(Castro et al., 1999). While TCDD inhibited E2-enhanced procathespin D secretion in PE04 ER+
human ovarian cancer cells and Hep-1 cells (Rowlands et al., 1993; Kharat et al., 1996), in
mutant Hep-1 cells deficient in functional AhR, TCCD was no longer inhibitory on estrogeninducible genes (Kharat et al., 1996).
The results of the present study may be due to APAP binding the AhR resulting in
inhibitory effects on E2 -responsive alkaline phosphatase activity in Ishikawa cells via an
interaction through AhR-ER crosstalk. Although the ERE for placental alkaline phosphatase in
Ishikawa cells has not been defined as a classical ERE, it is possible that placental alkaline
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phosphatase, an estrogen-responsive gene, contains an XRE-like sequence. Binding of the AhRAPAP complex to the XRE-like sequence of the promoter region of the alkaline phosphatase
gene would block the ER from binding the ERE. This might explain the non-competitive
inhibition of E2 -induced alkaline phosphatase activity and the inhibition of basal enzyme
activity as well. In addition, this AhR-APAP complex could bind and inhibit other genes
containing XRE-like sequences resulting in decreased cellular protein and possibly result in cell
toxicity. This hypothesis also can be extended to APAP’s ability to induce cell proliferation in
ER+/PR+ MCF7cells and inhibition of estrogen-dependent vitellogenin in trout liver cells.
Perhaps the APAP-AhR interferes with cell cycle-regulating protein in MCF7 cells; estrogendependent vitellogenin could have an XRE-like sequence in its ERE.

Significance
This study shows that APAP interferes with expression of estrogen-responsive genes in
Ishikawa endometrial carcinoma cells. Even more significant was the inhibitory effect on
estrogen-responsive alkaline phosphatase in Ishikawa cells compared to previous studies
showing stimulation of estrogen-responsive cell proliferation in MCF-7 human breast cancer
cells. Questions brought about by this study are two-fold: what is the mechanism behind APAP
inhibition of alkaline phosphatase in Ishikawa cells; why does APAP have different responses in
different cell types?
Ishikawa cells are a good model of estrogen-responsive cells and are currently being used
commercially as an in vitro estrogen-screen tool. The alkaline phosphatase assay is a simple and
inexpensive assay that can be used to screen multiple samples at a time by the microplate
method; however, the usefulness of estrogen screening by Ishikawa cells is limited and should be
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used as an initial indicator of potential estrogenic activity. Since in vitro studies do not address
questions such as metabolism and bioavailability of active compounds or their metabolites,
further investigation is necessary. Whole animal and human case studies need to be utilized to
determine actual estrogenic potential of any compound as it relates to human health.
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Future Studies
Studies by Barkhem et al. (1998) indicate that OHT, raloxifene and ICI 164,384 have an
ERα-selective partial agonist/antagonist activity, but act as pure antagonists through ERβ.
Although there have been two subtypes of ER characterized in Ishikawa cells (Kd. 0.2 and
0.6nM), these two ER subtypes have not been positively identified or quantified (Kassan et al.,
1989). Western blot using specific antibodies could identify ER subtypes α and β present in
Ishikawa cells. Identification of subtypes in Ishikawa cells may also shed some light on why
APAP has antagonist activity on alkaline phosphatase activity in Ishikawa cells, yet had
estrogen-like activity in ER+/PR+ breast cancer cell proliferation studies. Differences in the
presence of ER subtypes may be the reason behind the agonist or antagonist activity of APAP in
particular cell types.
Crosstalk between ER and AhR in Ishikawa cells, through APAP interaction with the
AhR, is also a possible mechanism that would produce inhibition of estrogen-responsive genes.
A recent study by Wormke et al. (2000) has shown that AhR and its associated proteins are
expressed in Ishikawa cells. Treatment with TCDD and other AhR agonists inhibited E2-induced
responses such cell proliferation and transcriptional activation assays (Wormke et al., 2000).
Future experiments should be aimed at determining if APAP binds AhR in ligand-binding assays
and if TCDD inhibits alkaline phosphatase activity in Ishikawa cells.
It is also unclear if APAP is specifically targeting an estrogen-responsive gene or perhaps
just targeting regulation of alkaline phosphatase. To answer this question other estrogenresponsive genes in Ishikawa cells such as progesterone receptor induction and cell proliferation
could be examined. If APAP were acting through an ER-mediated pathway then inhibition of
these estrogen-regulated processes would be expected. To answer the question of APAP
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specificity for alkaline phosphatase, T47D breast cancer cells could be used since the alkaline
phosphatase activity expressed in that cell line is progesterone-induced and estrogenunresponsive (Di Lorenzo et al., 1991). The expected results would be no change in enzyme
activity with APAP treatment in T47D cells.
This study has evoked many questions and directions for future studies in the area of
APAP and its interaction with estrogen-responsive genes in vitro. The studies suggested would
enhance the understanding of ER-responsive gene regulation in estrogen-sensitive cells, as well
as the many different possible mechanisms involved in the inhibitory process.
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